Biogen Inc (NASDAQ:BIIB) under-valued by 13%
Website | https://www.biogen.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2019 |
Market Cap | $44,329,222,000 |
Beta | 0.57477 |
Average Volume | $1,142,596 |
Last Dividend | 0% |
Price on Jul 22, 2020 | $280.63 |
Autochartist™ Valuation | $316.45 |
Conclusion |
13% under-valued |
Download Report |